Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

Screening iconoclasm

Artificial intelligence in pathology may open the door for many more cancers to be preventable

May 7, 2021 Judith Offman 0

In this piece PRISM researchers discuss how the use of artificial intelligence in pathology can open up new pathways towards the early diagnosis of cancer. […]

Artificial Intelligence in breast cancer screening – part 4: personalising screening

January 23, 2020 Peter Sasieni 0

In the final of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider how AI could be used […]

Artificial Intelligence in breast cancer screening – part 3: implications for the UK

January 15, 2020 Peter Sasieni 0

In the third of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider what might be the implications […]

breast cancer

Artificial Intelligence in breast cancer screening – part 2: international differences

January 8, 2020 Peter Sasieni 0

Previously we reported on a major study evaluating AI as a tool to identify breast cancer on mammography. The results were impressive. In the UK, […]

Artificial Intelligence in breast cancer screening – part 1: are computers developing 20/20 vision?

January 1, 2020 Peter Sasieni 1

Despite many technological advances in mammographic imaging over the last century, breast cancer screening is largely the same as it was when first studied 60 […]

Which screening guidelines are woefully inadequate?

September 20, 2019 Peter Sasieni 0

Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof […]

Isolines and Rabbit Holes: Adventures in ROC Space

August 2, 2019 Peter Sasieni 0

There is an apocryphal story about Queen Victoria. Having enjoyed Alice’s Adventures in Wonderland, the queen requested a copy of Lewis Carroll’s next book. Carroll, […]

Equality and Equity in Cancer Screening: How can we personalise interventions and still be fair?

July 19, 2019 Peter Sasieni 3

The classic American illustration explaining the difference between equity and equality  is of three people trying to watch a baseball game from behind a fence. […]

Screening iconoclasm series: Is it time for cancer screening to become non-binary?

March 22, 2019 Peter Sasieni 0

In our final iconoclasm series post, Peter Sasieni explores the merits of making cancer screening non-binary. The classic paradigm for diagnostic testing and medical screening […]

Screening iconoclasm series: Could you be more specific about what you mean by specificity?

March 15, 2019 Peter Sasieni 0

In this post, Peter Sasieni argues that it is time to be more specific about our definitions of specificity and false positive tests. How will […]

Screening iconoclasm series: Are you putting too much value on positive predictive value?

February 21, 2019 Peter Sasieni 0

If you read the previous blog from the screening iconoclast and know a little about screening, you might be thinking that the thing to do […]

Posts navigation

1 2 »

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Cancer Research UK Cambridge Centre Early Detection Programme

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • HPV Vaccination in Japan: The Journey to Resuming a National Immunisation Programme
  • ‘The tragedy of thousands who need not die’: A history of cervical screening in England Part I
  • PODCAST: Remote Consultations in Primary Care
  • What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening?
  • Building back better: How can cancer screening & prevention level up?
  • Pride in Research: The legacy of erasure and the future of LGBT+ inclusive trials
  • Will remote consultations help us to achieve earlier diagnosis of cancer?
  • Supporting women through a cancer diagnosis: an interview with Rachel Baker
  • Building informed consent – the importance of trust and transparency in safe health data sharing practices
  • There are things we can do to make increased cervical screening intervals more acceptable
Barrett’s oesophagus Best 3 Breast cancer screening cancer prevention cancer screening cervical cancer cervical screening Clinical research network COVID-19 Cytosponge™ ethics five minutes with HPV HPV primary screening HPV vaccination mammography medical research Oesophageal cancer prevention public health public policy screening sensitivity Upper GI Women in Science
  • What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening? – Cancer Prevention Group Blog: […] Autumn, we posted a blog that outlined why the introduction of risk-stratification to the NHS Breast Screening Programme is…
  • Building back better: How can cancer screening & prevention level up? – Cancer Prevention Group Blog: […] In the wake of the COVID-19 pandemic, the current government has committed to ‘building back better’ and ‘levelling up’…
  • Pride in Research: The legacy of erasure and the future of LGBT+ inclusive trials – Cancer Prevention Group Blog: […] Much like other marginalised communities, there is a historical mistrust of health institutions in the queer community, as a…
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2022 | WordPress Theme by MH Themes